Hearing for HHS nominee Azar dominated by drug pricing issue

0
178
Both sides of the aisle — and even the former Eli Lilly exec himself — expressed concerns over the ballooning drug prices and stressed the need to make pharmaceuticals more affordable.

Healthcarecare Finance News Feed

LEAVE A REPLY